Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dosing and Deployment Trial: A Home-based Optokinetic Treatment for Ipsilesional Gaze Deviation

NCT07519317 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT07519317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07519317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dosing and Deployment Trial: A Home-based Optokinetic Treatment for Ipsilesional Gaze Deviation
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 4, 2027
Completion date
June 16, 2028
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

spatial neglect